AQR Capital Management Portfolio holdings
AUM
$121B
1-Year Return
23.38%
This Quarter Return
+3.72%
1 Year Return
+23.38%
3 Year Return
+85.44%
5 Year Return
+156.19%
10 Year Return
+370.97%
AUM
$99.3B
AUM Growth
+$6.55B
(+7.1%)
Cap. Flow
+$5.03B
Cap. Flow
% of AUM
5.06%
Top 10 Holdings %
Top 10 Hldgs %
12.45%
Holding
2,453
New
237
Increased
1,041
Reduced
973
Closed
144
Top Buys
| 1 |
Valero Energy
VLO
|
+$393M |
| 2 |
Booking.com
BKNG
|
+$308M |
| 3 |
RTN
Raytheon Company
RTN
|
+$298M |
| 4 |
ConocoPhillips
COP
|
+$294M |
| 5 |
FedEx
FDX
|
+$281M |
Top Sells
| 1 |
Walt Disney
DIS
|
+$299M |
| 2 |
Western Digital
WDC
|
+$263M |
| 3 |
CELG
Celgene Corp
CELG
|
+$250M |
| 4 |
United Airlines
UAL
|
+$248M |
| 5 |
JPMorgan Chase
JPM
|
+$197M |
Sector Composition
| 1 | Technology | 19.77% |
| 2 | Consumer Discretionary | 13.83% |
| 3 | Healthcare | 13.28% |
| 4 | Industrials | 12.34% |
| 5 | Financials | 12.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Verastem
VSTM
$608M
| $464K | ﹤0.01% |
+5,619
| New | +$464K |
|
|
GTHX
2002
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $464K | ﹤0.01% |
+10,670
| New | +$464K |
|
2003
Descartes Systems
DSGX
$9.1B
| $462K | ﹤0.01% |
14,201
+1,665
| +13% | +$54.2K |
|
2004
US Physical Therapy
USPH
$1.23B
| $460K | ﹤0.01% |
4,794
-37
| -0.8% | -$3.55K |
|
2005
Freshpet
FRPT
$2.61B
| $456K | ﹤0.01% |
16,599
-69
| -0.4% | -$1.9K |
|
2006
Voyager Therapeutics
VYGR
$231M
| $456K | ﹤0.01% |
+23,327
| New | +$456K |
|
2007
Badger Meter
BMI
$5.23B
| $454K | ﹤0.01% |
10,162
| – | – |
|
2008
Quaker Houghton
KWR
$2.42B
| $454K | ﹤0.01% |
2,929
-531
| -15% | -$82.3K |
|
|
BHR
2009
Braemar Hotels & Resorts
BHR
$199M
| $453K | ﹤0.01% |
40,041
-433
| -1% | -$4.9K |
|
2010
First Foundation Inc
FFWM
$487M
| $449K | ﹤0.01% |
24,198
-2,834
| -10% | -$52.6K |
|
2011
Kinsale Capital Group
KNSL
$9.92B
| $449K | ﹤0.01% |
+8,176
| New | +$449K |
|
2012
Schneider National
SNDR
$4.18B
| $449K | ﹤0.01% |
+16,325
| New | +$449K |
|
2013
Esperion Therapeutics
ESPR
$524M
| $448K | ﹤0.01% |
11,442
-51,894
| -82% | -$2.03M |
|
|
SEI
2014
Solaris Energy Infrastructure, Inc.
SEI
$1.31B
| $445K | ﹤0.01% |
+31,170
| New | +$445K |
|
2015
Golden Entertainment
GDEN
$634M
| $444K | ﹤0.01% |
16,456
-49,602
| -75% | -$1.34M |
|
2016
Mesa Laboratories
MLAB
$327M
| $443K | ﹤0.01% |
2,097
-1,186
| -36% | -$251K |
|
|
FLOW
2017
DELISTED
SPX FLOW, Inc.
FLOW
| $442K | ﹤0.01% |
10,100
+2,805
| +38% | +$123K |
|
|
ACBI
2018
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $442K | ﹤0.01% |
22,475
+4,740
| +27% | +$93.2K |
|
2019
Albemarle
ALB
$8.63B
| $441K | ﹤0.01% |
4,677
-14,161
| -75% | -$1.34M |
|
|
ITCI
2020
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $441K | ﹤0.01% |
+24,966
| New | +$441K |
|
2021
Dine Brands
DIN
$361M
| $440K | ﹤0.01% |
+5,883
| New | +$440K |
|
2022
Forward Air
FWRD
$913M
| $438K | ﹤0.01% |
7,419
+2,028
| +38% | +$120K |
|
|
CORE
2023
DELISTED
Core Mark Holding Co., Inc.
CORE
| $435K | ﹤0.01% |
19,165
-21,406
| -53% | -$486K |
|
2024
Fabrinet
FN
$13.3B
| $433K | ﹤0.01% |
+11,731
| New | +$433K |
|
2025
Flotek Industries
FTK
$331M
| $433K | ﹤0.01% |
22,340
+17,502
| +362% | +$339K |
|